Bhupesh Sharma Selected Research

Glutathione (Reduced Glutathione)

1/2022	Neurobehavioral and neurobiochemical effect of atomoxetine and N-acetylcysteine in streptozotocin diabetes induced endothelial dysfunction and related dementia.
11/2021	Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress.
8/2021	Efficacy of Ulinastatin and Sulforaphane Alone or in Combination in Rat Model of Streptozotocin Diabetes Induced Vascular Dementia.
6/2021	Behavioral and biochemical investigations to explore the efficacy of quercetin and folacin in experimental diabetes induced vascular endothelium dysfunction and associated dementia in rats.
12/2020	Possible involvement of D2/D3 receptor activation in ischemic preconditioning mediated protection of the brain.
1/2020	Agonism of Histaminergic-H1 Receptors in Ischemic Postconditioning During Cerebral Ischemia-Reperfusion Injury is Protective.
9/2019	A selective peroxisome proliferator-activated receptor-γ agonist benefited propionic acid induced autism-like behavioral phenotypes in rats by attenuation of neuroinflammation and oxidative stress.
8/2019	Beneficial effects of pioglitazone, a selective peroxisome proliferator-activated receptor-γ agonist in prenatal valproic acid-induced behavioral and biochemical autistic like features in Wistar rats.
1/2019	Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
12/2018	Selective modulator of peroxisome proliferator-activated receptor-α protects propionic acid induced autism-like phenotypes in rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bhupesh Sharma Research Topics

Disease

24	Inflammation (Inflammations) 01/2022 - 06/2014
19	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 06/2022 - 08/2010
11	Dementia (Dementias) 01/2022 - 03/2008
11	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 04/2015
9	Body Weight (Weight, Body) 01/2022 - 08/2010
9	Cognitive Dysfunction 11/2016 - 08/2010
7	Hypertension (High Blood Pressure) 06/2022 - 07/2012
7	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 03/2008
6	Autism Spectrum Disorder 10/2021 - 12/2015
5	Infarction (Infarctions) 12/2020 - 01/2016
5	Autistic Disorder (Autism) 09/2019 - 01/2016
5	Brain Infarction 09/2016 - 05/2014
5	Memory Disorders (Memory Loss) 01/2015 - 03/2008
4	Renovascular Hypertension (Goldblatt Syndrome) 06/2022 - 04/2015
4	Neuroinflammatory Diseases 09/2019 - 12/2018
3	Brain Diseases (Brain Disorder) 10/2021 - 08/2019
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2016 - 06/2014
2	Experimental Diabetes Mellitus 01/2022 - 08/2021
2	Brain Ischemia (Cerebral Ischemia) 01/2020 - 01/2014
2	Huntington Disease (Huntington's Disease) 07/2014 - 03/2014
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 02/2021

Drug/Important Bio-Agent (IBA)

29	Glutathione (Reduced Glutathione)IBA 01/2022 - 06/2011
21	thiobarbituric acidIBA 01/2022 - 06/2011
17	Thiobarbituric Acid Reactive SubstancesIBA 01/2022 - 06/2011
17	NitratesIBA 01/2022 - 08/2010
17	NitritesIBA 01/2022 - 08/2010
16	AcetylcholinesteraseIBA 01/2022 - 08/2010
16	CatalaseIBA 01/2022 - 05/2014
13	Superoxide DismutaseIBA 01/2022 - 05/2014
12	Peroxidase (Myeloperoxidase)IBA 01/2020 - 06/2014
10	CalciumIBA 10/2016 - 01/2015
9	Superoxides (Superoxide)IBA 01/2022 - 06/2011
9	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2010
8	Cholinergic Agents (Cholinergics)IBA 11/2016 - 01/2015
7	Streptozocin (Streptozotocin)FDA Link 01/2022 - 03/2008
6	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022 - 01/2021
6	Valproic Acid (Depakote)FDA LinkGeneric 11/2021 - 12/2015
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2019 - 06/2013
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 12/2018
4	vinpocetineIBA 01/2022 - 06/2014
4	Transcription Factors (Transcription Factor)IBA 11/2021 - 01/2021
4	Neuroprotective AgentsIBA 01/2020 - 01/2015
4	Interleukin-6 (Interleukin 6)IBA 09/2019 - 12/2018
4	Interleukin-10 (Interleukin 10)IBA 09/2019 - 12/2018
4	ChloridesIBA 01/2016 - 01/2015
4	agomelatine (S20098)IBA 12/2015 - 07/2014
4	Malondialdehyde (Propanedial)IBA 01/2015 - 05/2014
3	InterleukinsIBA 01/2022 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
3	EnzymesIBA 10/2021 - 01/2015
3	PapaverineIBA 02/2021 - 01/2021
3	Pioglitazone (Actos)FDA Link 09/2019 - 10/2016
3	Nicorandil (SG 75)IBA 11/2016 - 06/2014
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 09/2016 - 01/2016
3	Donepezil (Aricept)FDA LinkGeneric 04/2015 - 03/2008
3	SaltsIBA 02/2013 - 07/2012
3	Desoxycorticosterone Acetate (DOCA)FDA Link 02/2013 - 07/2012
3	Acetates (Acetic Acid Esters)FDA Link 02/2013 - 07/2012
3	Desoxycorticosterone (Deoxycorticosterone)IBA 02/2013 - 07/2012
2	QuercetinIBA 06/2022 - 06/2021
2	urinastatin (MR 20)IBA 06/2022 - 08/2021
2	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2022 - 01/2021
2	Synapsins (Synapsin I)IBA 11/2021 - 01/2021
2	Folic Acid (Vitamin M)FDA LinkGeneric 06/2021 - 08/2012
2	Proteins (Proteins, Gene)FDA Link 02/2021 - 01/2021
2	PPAR gammaIBA 09/2019 - 08/2019
2	Therapeutic UsesIBA 09/2019 - 08/2019
2	propionic acid (potassium propionate)IBA 09/2019 - 12/2018
2	Fenofibrate (CiL)FDA LinkGeneric 01/2019 - 12/2018
2	Amyloid (Amyloid Fibrils)IBA 01/2019 - 03/2008
2	triphenyltetrazoliumIBA 11/2016 - 01/2016
2	Ruthenium RedIBA 10/2016 - 01/2016
2	AcidsIBA 09/2016 - 01/2016
2	Galactose (Galactopyranose)FDA LinkGeneric 01/2016 - 01/2016
2	Bosentan (Tracleer)FDA Link 01/2016 - 09/2014
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016 - 05/2014
2	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2016 - 05/2014
2	Serotonin (5 Hydroxytryptamine)IBA 01/2016 - 04/2015
2	Endothelins (Endothelin)IBA 01/2016 - 09/2014
2	Melatonin Receptors (Melatonin Receptor)IBA 12/2015 - 04/2015
2	Cholinesterases (Cholinesterase)IBA 01/2015 - 05/2014
2	NF-kappa B (NF-kB)IBA 03/2014 - 10/2012
2	moxonidine (Moxon)IBA 03/2014 - 01/2014
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2013 - 02/2013
2	Butyric Acid (Butanoic Acid)IBA 11/2013 - 06/2011
2	Telmisartan (Micardis)FDA Link 06/2013 - 07/2012
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2013 - 10/2012
2	Lisinopril (Prinivil)FDA LinkGeneric 06/2013 - 10/2012
2	Angiotensin Receptor AntagonistsIBA 06/2013 - 07/2012
2	NADPH Oxidases (NAD(P)H oxidase)IBA 02/2013 - 08/2010
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 07/2012 - 03/2008
2	pitavastatin (itavastatin)FDA Link 08/2010 - 03/2008
2	Celecoxib (Celebrex)FDA Link 06/2008 - 03/2008
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2022
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2022
1	Cilostazol (Pletal)FDA LinkGeneric 10/2021
1	sulforaphaneIBA 08/2021

Therapy/Procedure

3	Surgical Instruments (Clip) 06/2022 - 04/2015
2	Pancreatectomy 10/2016 - 12/2015
2	Ligation 04/2015 - 01/2014